Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carotid Artery Diseases | 30 | 2023 | 882 | 8.180 |
Why?
|
Intracranial Arteriosclerosis | 11 | 2023 | 135 | 5.670 |
Why?
|
Calcinosis | 19 | 2023 | 1497 | 4.450 |
Why?
|
Carotid Stenosis | 11 | 2023 | 854 | 2.590 |
Why?
|
Plaque, Atherosclerotic | 17 | 2023 | 1499 | 2.400 |
Why?
|
Carotid Artery, Internal | 11 | 2021 | 445 | 2.370 |
Why?
|
Netherlands | 36 | 2022 | 2170 | 2.190 |
Why?
|
Stroke | 33 | 2023 | 9963 | 2.170 |
Why?
|
Carotid Arteries | 18 | 2023 | 952 | 2.050 |
Why?
|
Atherosclerosis | 17 | 2023 | 3428 | 1.900 |
Why?
|
Dementia | 15 | 2023 | 2501 | 1.650 |
Why?
|
Aortic Valve Stenosis | 7 | 2023 | 1941 | 1.510 |
Why?
|
Aorta, Thoracic | 9 | 2022 | 1080 | 1.500 |
Why?
|
Coronary Artery Disease | 17 | 2023 | 6454 | 1.480 |
Why?
|
Aortography | 3 | 2021 | 431 | 1.430 |
Why?
|
Aortic Valve | 7 | 2023 | 1911 | 1.380 |
Why?
|
Aortic Diseases | 4 | 2021 | 741 | 1.230 |
Why?
|
Pericardium | 6 | 2022 | 667 | 1.160 |
Why?
|
Lipoprotein(a) | 4 | 2023 | 425 | 1.080 |
Why?
|
Arteriosclerosis | 3 | 2024 | 1092 | 0.930 |
Why?
|
Basilar Artery | 3 | 2021 | 200 | 0.860 |
Why?
|
Risk Factors | 60 | 2023 | 72145 | 0.840 |
Why?
|
Aged | 90 | 2024 | 162944 | 0.800 |
Why?
|
Hyperlipoproteinemias | 1 | 2021 | 20 | 0.790 |
Why?
|
Lipid Regulating Agents | 1 | 2021 | 24 | 0.790 |
Why?
|
Clinical Medicine | 1 | 2022 | 147 | 0.750 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2021 | 114 | 0.730 |
Why?
|
Coronary Vessels | 13 | 2024 | 3099 | 0.720 |
Why?
|
Adipose Tissue | 7 | 2022 | 3278 | 0.650 |
Why?
|
Vertebral Artery | 1 | 2019 | 192 | 0.630 |
Why?
|
Coronary Angiography | 7 | 2024 | 4567 | 0.630 |
Why?
|
Tomography, X-Ray Computed | 25 | 2024 | 20086 | 0.630 |
Why?
|
Migraine Disorders | 4 | 2023 | 1620 | 0.620 |
Why?
|
Ischemic Attack, Transient | 3 | 2022 | 934 | 0.610 |
Why?
|
Cardiovascular Diseases | 14 | 2023 | 15108 | 0.590 |
Why?
|
Population Surveillance | 5 | 2019 | 2616 | 0.580 |
Why?
|
Hypercholesterolemia | 1 | 2023 | 1149 | 0.560 |
Why?
|
Male | 89 | 2024 | 349538 | 0.560 |
Why?
|
Calcium | 8 | 2023 | 5753 | 0.550 |
Why?
|
Prospective Studies | 33 | 2024 | 53187 | 0.530 |
Why?
|
Humans | 133 | 2024 | 742088 | 0.520 |
Why?
|
Female | 89 | 2024 | 379592 | 0.520 |
Why?
|
Magnetic Resonance Angiography | 3 | 2022 | 1440 | 0.510 |
Why?
|
Middle Aged | 66 | 2024 | 213127 | 0.510 |
Why?
|
Fibrinolytic Agents | 3 | 2022 | 2156 | 0.500 |
Why?
|
Glomerular Filtration Rate | 2 | 2019 | 2167 | 0.490 |
Why?
|
Magnetic Resonance Imaging | 32 | 2024 | 35342 | 0.480 |
Why?
|
Brain Ischemia | 8 | 2023 | 3258 | 0.470 |
Why?
|
Cognition Disorders | 5 | 2018 | 4030 | 0.440 |
Why?
|
Apolipoprotein E4 | 1 | 2017 | 667 | 0.430 |
Why?
|
Cerebrovascular Disorders | 3 | 2021 | 1499 | 0.430 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 2195 | 0.420 |
Why?
|
Cohort Studies | 26 | 2023 | 40450 | 0.420 |
Why?
|
Incidental Findings | 1 | 2016 | 688 | 0.390 |
Why?
|
Brain Diseases | 2 | 2020 | 1554 | 0.380 |
Why?
|
Hemorrhage | 8 | 2022 | 3461 | 0.380 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2145 | 0.360 |
Why?
|
Brain | 14 | 2023 | 26343 | 0.350 |
Why?
|
Risk Assessment | 17 | 2023 | 23320 | 0.350 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15530 | 0.340 |
Why?
|
Longitudinal Studies | 9 | 2023 | 13921 | 0.340 |
Why?
|
Necrosis | 3 | 2022 | 1643 | 0.330 |
Why?
|
Prevalence | 9 | 2021 | 15194 | 0.330 |
Why?
|
Cerebrovascular Circulation | 5 | 2023 | 2732 | 0.320 |
Why?
|
Predictive Value of Tests | 8 | 2023 | 15056 | 0.320 |
Why?
|
Health Status Disparities | 1 | 2019 | 1794 | 0.310 |
Why?
|
Atrophy | 3 | 2021 | 1576 | 0.310 |
Why?
|
Kidney Diseases | 1 | 2019 | 2145 | 0.300 |
Why?
|
Coronary Disease | 5 | 2023 | 6078 | 0.300 |
Why?
|
Aging | 5 | 2023 | 8626 | 0.290 |
Why?
|
Lipids | 4 | 2022 | 3302 | 0.290 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3507 | 0.280 |
Why?
|
Atrial Fibrillation | 3 | 2022 | 5019 | 0.280 |
Why?
|
Thyrotropin | 2 | 2022 | 850 | 0.270 |
Why?
|
Thyroxine | 2 | 2022 | 666 | 0.270 |
Why?
|
Cardiology | 1 | 2016 | 1658 | 0.260 |
Why?
|
Creatinine | 2 | 2022 | 1916 | 0.260 |
Why?
|
Cerebral Hemorrhage | 3 | 2022 | 2643 | 0.250 |
Why?
|
Risk | 7 | 2020 | 9679 | 0.250 |
Why?
|
Lung Transplantation | 2 | 2023 | 1155 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 6 | 2021 | 17400 | 0.240 |
Why?
|
Intracranial Hemorrhages | 2 | 2020 | 854 | 0.240 |
Why?
|
Aged, 80 and over | 21 | 2021 | 57683 | 0.240 |
Why?
|
Noma | 1 | 2023 | 8 | 0.230 |
Why?
|
Genetic Loci | 3 | 2021 | 2572 | 0.230 |
Why?
|
Incidence | 10 | 2021 | 20928 | 0.220 |
Why?
|
Pseudoxanthoma Elasticum | 1 | 2022 | 12 | 0.210 |
Why?
|
Blood Pressure | 4 | 2022 | 8541 | 0.210 |
Why?
|
Hyperphosphatemia | 1 | 2022 | 40 | 0.210 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3239 | 0.210 |
Why?
|
Life Expectancy | 2 | 2019 | 1183 | 0.210 |
Why?
|
Registries | 3 | 2020 | 8077 | 0.210 |
Why?
|
Linear Models | 5 | 2019 | 5948 | 0.200 |
Why?
|
Cognition | 5 | 2024 | 6722 | 0.200 |
Why?
|
Prognosis | 12 | 2021 | 29010 | 0.190 |
Why?
|
Follow-Up Studies | 11 | 2020 | 39004 | 0.190 |
Why?
|
Smoking | 2 | 2020 | 8969 | 0.190 |
Why?
|
Pulmonary Artery | 2 | 2021 | 1911 | 0.190 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 3038 | 0.190 |
Why?
|
Sex Factors | 5 | 2022 | 10392 | 0.190 |
Why?
|
Cross-Sectional Studies | 14 | 2023 | 24913 | 0.180 |
Why?
|
Tacrolimus | 1 | 2023 | 741 | 0.180 |
Why?
|
Alzheimer Disease | 4 | 2024 | 7988 | 0.170 |
Why?
|
Ultrasonography | 3 | 2021 | 5978 | 0.170 |
Why?
|
Phantoms, Imaging | 3 | 2024 | 2466 | 0.170 |
Why?
|
Neurofibrillary Tangles | 1 | 2021 | 437 | 0.160 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2019 | 143 | 0.160 |
Why?
|
Tunica Media | 1 | 2018 | 113 | 0.160 |
Why?
|
Carotid Artery, External | 1 | 2018 | 38 | 0.160 |
Why?
|
Thyroid Diseases | 1 | 2022 | 378 | 0.160 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 238 | 0.160 |
Why?
|
Ketone Bodies | 1 | 2018 | 81 | 0.160 |
Why?
|
Principal Component Analysis | 1 | 2021 | 939 | 0.160 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2018 | 87 | 0.160 |
Why?
|
Cystatin C | 1 | 2019 | 250 | 0.150 |
Why?
|
Pulmonary Heart Disease | 1 | 2017 | 36 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8925 | 0.150 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2017 | 87 | 0.150 |
Why?
|
Cerebral Arteries | 2 | 2019 | 492 | 0.150 |
Why?
|
Blood Glucose | 3 | 2020 | 6249 | 0.150 |
Why?
|
Kidney Function Tests | 1 | 2019 | 683 | 0.140 |
Why?
|
Exercise Therapy | 2 | 2020 | 904 | 0.140 |
Why?
|
Tunica Intima | 1 | 2018 | 464 | 0.140 |
Why?
|
Aorta | 3 | 2021 | 2057 | 0.140 |
Why?
|
MicroRNAs | 2 | 2023 | 3731 | 0.130 |
Why?
|
Neuropsychological Tests | 4 | 2018 | 6974 | 0.130 |
Why?
|
Logistic Models | 5 | 2020 | 13403 | 0.130 |
Why?
|
Blood Flow Velocity | 1 | 2019 | 1423 | 0.130 |
Why?
|
Adaptive Immunity | 1 | 2020 | 712 | 0.130 |
Why?
|
Thrombectomy | 1 | 2020 | 679 | 0.130 |
Why?
|
Cost of Illness | 2 | 2022 | 1852 | 0.130 |
Why?
|
Electrocardiography | 2 | 2019 | 6440 | 0.120 |
Why?
|
Epidemiologic Studies | 1 | 2018 | 676 | 0.120 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1095 | 0.120 |
Why?
|
Radiography | 2 | 2016 | 7010 | 0.120 |
Why?
|
Parkinsonian Disorders | 1 | 2017 | 272 | 0.120 |
Why?
|
Disease Progression | 2 | 2021 | 13256 | 0.120 |
Why?
|
Cerebral Revascularization | 1 | 2016 | 238 | 0.120 |
Why?
|
Diabetes Complications | 1 | 2021 | 1359 | 0.120 |
Why?
|
Proportional Hazards Models | 6 | 2022 | 12344 | 0.120 |
Why?
|
Glycolysis | 1 | 2018 | 825 | 0.120 |
Why?
|
Random Allocation | 1 | 2018 | 2425 | 0.120 |
Why?
|
Microvessels | 1 | 2018 | 544 | 0.120 |
Why?
|
Heart Failure | 3 | 2023 | 10856 | 0.110 |
Why?
|
Lipoproteins | 1 | 2018 | 876 | 0.110 |
Why?
|
Liver Diseases | 1 | 2020 | 1252 | 0.100 |
Why?
|
Endovascular Procedures | 3 | 2020 | 1973 | 0.100 |
Why?
|
Hearing Loss | 1 | 2019 | 765 | 0.100 |
Why?
|
Hypertension | 2 | 2023 | 8455 | 0.100 |
Why?
|
Community Health Planning | 3 | 2017 | 165 | 0.100 |
Why?
|
Extracellular Fluid | 1 | 2013 | 166 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2059 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2211 | 0.100 |
Why?
|
Coffee | 1 | 2016 | 578 | 0.100 |
Why?
|
Radiation Dosage | 1 | 2020 | 1927 | 0.100 |
Why?
|
Metabolome | 1 | 2018 | 881 | 0.100 |
Why?
|
Intracranial Aneurysm | 1 | 2020 | 1197 | 0.090 |
Why?
|
Phenotype | 4 | 2023 | 16331 | 0.090 |
Why?
|
Beverages | 1 | 2016 | 820 | 0.090 |
Why?
|
Fatty Liver | 1 | 2016 | 728 | 0.090 |
Why?
|
Estradiol | 1 | 2017 | 2021 | 0.090 |
Why?
|
Glycoproteins | 1 | 2018 | 2260 | 0.090 |
Why?
|
Odds Ratio | 3 | 2017 | 9846 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1431 | 0.090 |
Why?
|
Cholesterol, LDL | 2 | 2016 | 2354 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2017 | 1155 | 0.080 |
Why?
|
Algorithms | 5 | 2021 | 13853 | 0.080 |
Why?
|
Dyslipidemias | 1 | 2016 | 848 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4249 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 2956 | 0.080 |
Why?
|
Age Distribution | 3 | 2020 | 2900 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6452 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2018 | 3760 | 0.080 |
Why?
|
Adiposity | 1 | 2017 | 1806 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2401 | 0.070 |
Why?
|
Nerve Net | 1 | 2019 | 2174 | 0.070 |
Why?
|
Spirometry | 2 | 2021 | 862 | 0.070 |
Why?
|
Hypertension, Pulmonary | 1 | 2017 | 1527 | 0.070 |
Why?
|
Age Factors | 2 | 2019 | 18355 | 0.070 |
Why?
|
Meta-Analysis as Topic | 2 | 2020 | 1342 | 0.060 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 12220 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6575 | 0.060 |
Why?
|
Genotype | 2 | 2019 | 12946 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1617 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5724 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2684 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6534 | 0.060 |
Why?
|
Bone Density | 1 | 2018 | 3469 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2020 | 5705 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15494 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2016 | 3748 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2017 | 2774 | 0.060 |
Why?
|
Sex Distribution | 2 | 2020 | 2295 | 0.060 |
Why?
|
Thyroid Gland | 2 | 2022 | 1172 | 0.050 |
Why?
|
Breath Tests | 1 | 2023 | 276 | 0.050 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 1183 | 0.050 |
Why?
|
Cardiac Volume | 1 | 2022 | 210 | 0.050 |
Why?
|
Reperfusion | 1 | 2023 | 284 | 0.050 |
Why?
|
Spin Labels | 1 | 2023 | 332 | 0.050 |
Why?
|
Thyroid Function Tests | 1 | 2022 | 284 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 25575 | 0.050 |
Why?
|
Body Fat Distribution | 1 | 2022 | 244 | 0.050 |
Why?
|
Hippocampus | 3 | 2020 | 3661 | 0.050 |
Why?
|
Depression | 1 | 2020 | 7733 | 0.050 |
Why?
|
Heart | 2 | 2024 | 4462 | 0.050 |
Why?
|
Diet | 1 | 2018 | 7923 | 0.040 |
Why?
|
Cholesterol | 2 | 2022 | 2895 | 0.040 |
Why?
|
Vital Capacity | 1 | 2021 | 922 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1661 | 0.040 |
Why?
|
Medical Futility | 1 | 2020 | 126 | 0.040 |
Why?
|
Leukoaraiosis | 1 | 2020 | 120 | 0.040 |
Why?
|
Audiometry, Pure-Tone | 1 | 2019 | 204 | 0.040 |
Why?
|
Phosphates | 1 | 2022 | 786 | 0.040 |
Why?
|
Carotid Artery, Common | 1 | 2019 | 183 | 0.040 |
Why?
|
Stress, Mechanical | 1 | 2023 | 1684 | 0.040 |
Why?
|
Time Factors | 2 | 2021 | 40054 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2699 | 0.040 |
Why?
|
Chromans | 1 | 2018 | 122 | 0.040 |
Why?
|
Immune System | 1 | 2023 | 804 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1118 | 0.040 |
Why?
|
Cholesterol, HDL | 2 | 2016 | 1813 | 0.040 |
Why?
|
Perfusion Imaging | 1 | 2019 | 195 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11695 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2023 | 956 | 0.040 |
Why?
|
Survival Analysis | 2 | 2020 | 10248 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13019 | 0.040 |
Why?
|
Observer Variation | 2 | 2013 | 2593 | 0.040 |
Why?
|
Ankle Brachial Index | 1 | 2017 | 154 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2021 | 1741 | 0.040 |
Why?
|
Intra-Abdominal Fat | 1 | 2022 | 591 | 0.040 |
Why?
|
Triglycerides | 2 | 2016 | 2450 | 0.040 |
Why?
|
Infant | 1 | 2018 | 35070 | 0.030 |
Why?
|
Vitamin K | 1 | 2018 | 294 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2020 | 448 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 40955 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 2 | 2019 | 4029 | 0.030 |
Why?
|
ROC Curve | 1 | 2022 | 3528 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2502 | 0.030 |
Why?
|
tau Proteins | 1 | 2024 | 1860 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4771 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3328 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2019 | 1438 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 21719 | 0.030 |
Why?
|
Body Composition | 1 | 2022 | 2400 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2018 | 1285 | 0.030 |
Why?
|
Blood Platelets | 1 | 2023 | 2506 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2020 | 62966 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2011 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2207 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3266 | 0.030 |
Why?
|
Young Adult | 1 | 2018 | 56350 | 0.030 |
Why?
|
Retinal Vessels | 1 | 2017 | 769 | 0.030 |
Why?
|
Lung | 2 | 2021 | 9826 | 0.030 |
Why?
|
Mesencephalon | 1 | 2013 | 327 | 0.020 |
Why?
|
Inflammation | 2 | 2023 | 10578 | 0.020 |
Why?
|
Educational Status | 1 | 2019 | 2533 | 0.020 |
Why?
|
Automation | 1 | 2013 | 584 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2024 | 3574 | 0.020 |
Why?
|
Contrast Media | 1 | 2024 | 5295 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4929 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 552 | 0.020 |
Why?
|
Child | 1 | 2018 | 77478 | 0.020 |
Why?
|
Energy Intake | 1 | 2018 | 2147 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2013 | 545 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 85649 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3656 | 0.020 |
Why?
|
Skin | 1 | 2023 | 4353 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2023 | 3957 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 4983 | 0.020 |
Why?
|
Adult | 3 | 2018 | 213712 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2857 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 19862 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3070 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2018 | 2585 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77098 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6365 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9410 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1887 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11690 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3587 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6030 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 3067 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7770 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2736 | 0.020 |
Why?
|
Genetic Variation | 1 | 2019 | 6540 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5611 | 0.010 |
Why?
|
Anticoagulants | 1 | 2018 | 4595 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7716 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12773 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10372 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14720 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12695 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9144 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23387 | 0.010 |
Why?
|
Brain Mapping | 1 | 2015 | 6669 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168561 | 0.010 |
Why?
|
United States | 1 | 2020 | 69693 | 0.010 |
Why?
|